|Bid||1.2500 x 800|
|Ask||1.6700 x 1300|
|Day's Range||1.4800 - 1.5800|
|52 Week Range||0.9200 - 1.7400|
|Beta (3Y Monthly)||1.11|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 7, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.69|
Genesis Healthcare (GEN) delivered earnings and revenue surprises of 380.00% and -0.56%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
KENNETT SQUARE, Pa., Nov. 07, 2019 -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today.
KENNETT SQUARE, Pa., Nov. 06, 2019 -- Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced that 46 Genesis skilled nursing.
Genesis Healthcare's (GEN) third-quarter results are likely to reflect weak revenues, partially offset by same store facility growth and lower expenses.
KENNETT SQUARE, Pa., Oct. 31, 2019 -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it.
Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare
Global economy is slowing down and IMF has turned pessimistic. This is the perfect time for investors to go defensive and invest in these five stocks.
The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet
Genesis HealthCare (Genesis or the Company), one of the nation’s largest providers of post-acute care services, today announced that it has made an investment with a private investor involving 18 skilled nursing facilities previously leased by Genesis from Second Spring Healthcare Investments (Second Spring) and Welltower Inc. (Welltower). Separately, eight owned facilities were sold to third parties for total sale proceeds of approximately $89 million. Proceeds were used to repay indebtedness and fund transaction expenses.
Genesis Healthcare (GEN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.